Published ahead of print on July 13, 2006, doi:10.1164/rccm.200601-074OC Am. J. Respir. Crit. Care Med., Volume 174, Number 7, October 2006, 817-823 A more recent version of this article appeared on October 1, 2006
Submitted on January 17, 2006 The Bacteriology of Pleural Infection by Genetic and Standard Methods and its Mortality SignificanceNick A Maskell1,1 Department of Respiratory Medicine, Southmead Hospital, Bristol, United Kingdom, 2 Department of Microbiology, Royal Free Hospital, London, United Kingdom, 3 Oxford Centre for Respiratory Medicine, Oxford Pleural Unit, Oxford Radcliffe Hospital, Oxford, United Kingdom, 4 Department of Respiratory Medicine, Royal Berkshire Hospital, Reading, United Kingdom * To whom correspondence should be addressed. E-mail: robert.davies{at}ndm.ox.ac.uk, robert.davies@clinical-medicine.oxford.ac.uk.
Background: Antibiotic choices for pleural infection are uncertain as its bacteriology is poorly described.
Methods: Pleural fluid from 434 pleural infections underwent standard culture and a screen for bacteria by amplification and sequencing of bacterial 16S ribosomal RNA gene.
Results: 50% of community acquired infections were streptococcal. 20% included anaerobic bacteria. 60% of hospital acquired infections included bacteria frequently resistant to antibiotics (MRSA 25%, Enterobacteriaceae 18%, Pseudomonas spp. 5%, enterococci 12%). Mortality was increased in hospital acquired infection (hospital 17/36, 47%, community 53/304, 17%, relative risk 4.24, 95% C.I. 2.07 to 8.69, p<0.00001, Key words: Bacteriology; Pleural infection; Parapneumonic effusion; ISRCTN 39138989; Polymerase chain reaction;
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||